退伍軍人菌檢測的全球市場

預計到 2030 年全球退伍軍人菌檢測市場規模將達到 5.517 億美元

2024 年全球退伍軍人菌檢測市場規模估計為 3.43 億美元，預計到 2030 年將達到 5.517 億美元，2024 年至 2030 年的複合年成長率為 8.2%。文化是報告中分析的細分市場之一，預計到分析期結束時，複合年成長率為 8.5%，達到 1.224 億美元。在分析期內，尿液抗原檢測 (UAT) 部分預計將以 8.6% 的複合年成長率成長。

美國市場規模估計為 8,840 萬美元，中國市場預計複合年成長率為 12.1%

預計 2024 年美國退伍軍人菌檢測市場價值將達到 8,840 萬美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 1.389 億美元，2024-2030 年分析期間的複合年成長率為 12.1%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 4.3% 和 7.3%。在歐洲，德國的複合年成長率預計為 5.1%。

全球退伍軍人菌檢測市場 - 主要趨勢與促進因素摘要

為什麼退伍軍人菌檢測在各行業變得越來越重要？

隨著全球對公共衛生和水安全意識的增強，退伍軍人菌檢測變得越來越重要。退伍軍人菌主要存在於供水系統中，可導致退伍軍人菌病，一種嚴重的肺炎。大型供水系統在醫院、飯店和公共建築等設施中普遍存在，因此定期檢測退伍軍人菌對於預防感染疾病爆發和確保居住者安全至關重要。在政府標準和公共衛生指南的推動下，人們對健康和安全法規的關注度不斷提高，增加了主動進行退伍軍人菌檢測的必要性，特別是在水安全政策嚴格的地區。

退伍軍人菌檢測市場有哪些技術進步？

技術進步徹底改變了退伍軍人菌檢測，使其在各種水系統中更快、更準確、更容易執行。傳統的培養方法需要大量的實驗室時間，而現在正被聚合酵素鏈鎖反應（PCR）測試、快速免疫檢測和酵素結合免疫吸附檢測法（ELISA）測試等更先進的技術所補充甚至取代。這些方法具有高靈敏度和特異性，可以快速檢測和定量退伍軍人菌。目前也提供可攜式檢測套組和自動採樣系統，可以進行現場測試。憑藉即時監測和早期檢測能力，這些創新提高了退伍軍人菌檢測的可靠性，使各行各業能夠採用更嚴格的水資源管理通訊協定。

哪些產業需要退伍軍人菌檢測？

由於法規遵循和公共衛生問題日益嚴重，醫療保健、飯店和水資源管理產業在採用退伍軍人菌檢測方面處於領先地位。醫院和養老院經常使用退伍軍人菌檢測來保護弱勢群體，而酒店業則使用它來確保住宿的安全。此外，工業設施、教育機構和市政供水系統正在將退伍軍人菌檢測納入其水安全計劃，以維持符合環境衛生法規。全球對永續水資源管理實踐的推動進一步鼓勵產業將退伍軍人菌檢測作為全面水風險評估的一部分。

退伍軍人菌檢測市場的成長受多種因素推動

退伍軍人菌檢測市場的成長受到多種因素的推動，例如健康意識的增強、監管要求和檢測方法的技術進步。已開發經濟體和新興經濟體日益嚴格的水質法規正促使各組織優先考慮退伍軍人菌控制計畫。醫療機構、飯店和其他需要定期檢測的高風險環境的增加也是一個主要促進因素。此外，快速檢測和現場診斷工具的創新正在擴大退伍軍人菌檢測的管道，使各部門更容易、更經濟高效地進行常規檢測。這些因素共同作用，使市場呈現上升趨勢。

部分

應用（臨床檢測、環境檢測）；最終用途（醫院、診斷實驗室、診所、其他最終用途）；檢測類型（培養、尿液抗原檢測 (UAT)、血清學、直接螢光抗體檢測 (DFA)、基於核酸的檢測）

受訪公司範例（41家值得關注的公司）

• Alere, Inc.
• Aquacert Ltd
• Beckman Coulter, Inc.
• Becton, Dickinson and Company（BD）
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Eiken Chemical Co., Ltd.
• Hologic, Inc.
• Idexx Laboratories Inc.
• Roche Diagnostics
• Thermo Fischer Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

• 市場概況
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲國家
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Legionella Testing Market to Reach US$551.7 Million by 2030

The global market for Legionella Testing estimated at US$343.0 Million in the year 2024, is expected to reach US$551.7 Million by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of the analysis period. Growth in the Urinary Antigen Test (UAT) segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.1% CAGR

The Legionella Testing market in the U.S. is estimated at US$88.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$138.9 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Legionella Testing Market - Key Trends & Drivers Summarized

Why Is Legionella Testing Gaining Importance Across Industries?

Legionella testing has become increasingly important as global awareness around public health and water safety intensifies. Legionella bacteria, primarily found in water systems, can cause Legionnaires' disease, a potentially severe form of pneumonia. Given the prevalence of large-scale water distribution systems in facilities like hospitals, hotels, and public buildings, regular testing for Legionella is essential to prevent outbreaks and ensure the safety of occupants. This rising focus on health and safety regulations, driven by government standards and public health guidelines, has elevated the need for proactive Legionella testing, particularly in regions with strict water safety policies.

How Is Technology Advancing in the Legionella Testing Market?

Technological advancements have transformed Legionella testing, making it faster, more accurate, and easier to conduct across various water systems. Traditional culture methods, which require extensive lab time, are being supplemented or replaced by advanced techniques like polymerase chain reaction (PCR) testing, rapid immunoassays, and enzyme-linked immunosorbent assay (ELISA) tests. These methods offer high sensitivity and specificity, allowing for faster detection and quantification of Legionella bacteria. Portable testing kits and automated sampling systems are now available, making it feasible to conduct on-site testing. With real-time monitoring and early detection capabilities, these technological innovations have made Legionella testing more reliable, allowing industries to adopt more stringent water management protocols.

Which Industries Are Embracing Legionella Testing?

The healthcare, hospitality, and water management industries are leading adopters of Legionella testing, driven by regulatory compliance and a heightened focus on public health. Hospitals and nursing homes rely on frequent Legionella testing to protect vulnerable populations, while the hospitality sector uses it to safeguard guests. Additionally, industrial facilities, educational institutions, and municipal water systems have integrated Legionella testing into their water safety plans to maintain compliance with environmental health regulations. The global push for sustainable water management practices has further encouraged industries to incorporate Legionella testing as part of comprehensive water risk assessments.

The Growth in the Legionella Testing Market Is Driven by Several Factors

The growth in the Legionella testing market is driven by several factors, including rising health awareness, regulatory requirements, and technological advancements in testing methodologies. Increased regulations around water quality in developed and emerging economies have spurred organizations to prioritize Legionella control programs. The growing number of healthcare facilities, hotels, and other high-risk environments that require regular testing is also a key driver. Additionally, innovations in rapid testing and on-site diagnostic tools have broadened access to Legionella testing, making it easier and more cost-effective for various sectors to implement routine testing. These factors collectively underscore the market's upward trajectory.

SCOPE OF STUDY:

The report analyzes the Legionella Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Clinical Testing Methods, Environmental Testing Methods); End-Use (Hospitals, Diagnostic Laboratories, Clinics, Other End-Uses); Test Type (Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA), Nucleic Acid-based Detection)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Alere, Inc.
• Aquacert Ltd
• Beckman Coulter, Inc.
• Becton, Dickinson and Company (BD)
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Eiken Chemical Co., Ltd.
• Hologic, Inc.
• Idexx Laboratories Inc.
• Roche Diagnostics
• Thermo Fischer Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Legionella Testing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Awareness of Waterborne Diseases Driving Demand for Testing
  • Increased Demand for Legionella Testing in Healthcare Facilities
  • Growth of the Hospitality Sector Requiring Routine Water Testing
  • Technological Advancements in Rapid Detection Methods
  • Expansion of Building and Facility Maintenance Practices for Water Safety
  • Growing Focus on Routine Testing in Public and Government Buildings
  • Adoption of Automated Testing Solutions for Efficient Water Monitoring
  • Increasing Demand for Point-of-Use Legionella Testing Kits
  • Increased Awareness of Health Risks Associated with Contaminated Water
  • Growth in Industrial Applications Requiring Legionella Control
  • Surge in Smart Water Management Systems for Continuous Monitoring
  • Development of Cost-Effective Testing Solutions for Broad Adoption
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Legionella Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Legionella Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Culture Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Culture Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Culture Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Urinary Antigen Test (UAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Urinary Antigen Test (UAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Urinary Antigen Test (UAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Serology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Serology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Serology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Direct Fluorescence Antibody Test (DFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Direct Fluorescence Antibody Test (DFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Direct Fluorescence Antibody Test (DFA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Nucleic Acid-based Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Nucleic Acid-based Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Nucleic Acid-based Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Clinical Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Clinical Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Clinical Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Environmental Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Environmental Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Environmental Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Legionella Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Legionella Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Legionella Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Legionella Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION